NEURONA THERAPEUTICS
Edit

NEURONA THERAPEUTICS

http://www.neuronatherapeutics.com/
Last activity: 06.12.2024
Active
Categories: DevelopmentIndustryNetworksPlatformProduct
Neurona is a cell therapy company focused on the development of breakthrough treatments for neurological disorders
Mentions
23
Location: United States, California, South San Francisco
Employees: 51-200
Total raised: $192.6M
Founded date: 2008

Investors 4

Funding Rounds 4

DateSeriesAmountInvestors
09.02.2024-$120M-
22.06.2021-$41.5M-
01.12.2015Series A$23.5MUCB Ventur...
24.12.2014-$7.6M-

Mentions in press and media 23

DateTitleDescription
06.12.2024Neurona Therapeutics Presents Positive Clinical Update: New Data from NRTX-1001 Cell Therapy Trial in Drug-resistant Epilepsy Announced at 2024 Annual Meeting of the American Epilepsy SocietySan Francisco, CA, December 6, 2024 – Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for epilepsy and other disorders of the nervous system, today announced positive clinical data from t...
10.09.2024Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy CandidateSAN FRANCISCO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced that the California Institute for Re...
12.03.2024Neurona Therapeutics to Present at Stifel 2024 Virtual CNS DaysSAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced that Cory R. Nichol...
12.03.2024Neurona Therapeutics to Present at Stifel 2024 Virtual CNS Days-
07.03.2024Neurona Therapeutics Announces Presentation of Updated Clinical Data at the Upcoming American Academy of Neurology (AAN) Annual Meeting from Lead Cell Therapy Candidate, NRTX-1001-
09.02.2024Neurona Therapeutics Raises $120M in FundingNeurona Therapeutics, a San Francisco, CA-based clinical-stage biotherapeutics company, raised $120M in funding. The round was led by Viking Global Investors and Cormorant Asset Management with participation from new and existing investors,...
08.02.2024Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological DisordersSan Francisco, CA, February 8, 2024 – Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced the successful completion of a ...
08.02.2024Neurona Therapeutics Lands $120M SAN FRANCISCO, CA, Neurona Therapeutics today announced the successful completion of a $120 million financing. >> Click here for more funding data on Neurona Therapeutics >> To export Neurona Therapeutics funding data to PDF...
08.02.2024Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders-
08.02.2024Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological DisordersThe financing, co-led by Viking Global Investors and Cormorant Asset Management with participation from The Column Group along with additional new and existing investors, follows promising early clinical data from NRTX-1001 epilepsy program...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In